SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors react to a significant debt reduction move involving bond-for-equity exchanges alongside an extension for its 10-K filing. The community remains hyper-focused on the company's turnaround narrative and its substantial stake in Babcock & Wilcox, with many traders actively discussing the potential for a short squeeze as the market digests the balance sheet restructuring.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is surging following its acquisition by Biogen for approximately $5.6 billion, a deal that highlights strong sector interest in commercial-stage biotech assets. The community is actively discussing the successful exit for long-term shareholders who weathered volatility, while investors are now pivoting to identify other potential M&A candidates within the broader biotechnology landscape.

"What's Updog?" is a Community Led token.

UpDog

The UpDog community is actively fueling momentum by leaning into the coin's signature humor and wordplay while highlighting its long-standing presence on the Solana network. Investors are frequently coordinating social media engagement and trending campaigns to build visibility for the project.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the announcement of $100 million in new financing, including a $75 million non-dilutive royalty agreement with Oberland Capital, which investors view as a key move to scale global operations and strengthen the company's balance sheet without significant dilution. While the stock continues to face intense pressure from short sellers and speculative volatility, the community is actively debating the impact of this capital injection on future growth, profitability timelines, and the potential for a short squeeze as the company expands its immunotherapy reach into new markets.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending following a strategic partnership with Nvidia and a two-billion-dollar investment aimed at scaling custom AI infrastructure, fueling excitement over potential data center dominance. Community sentiment is mixed as some investors celebrate the massive capital backing and future growth, while others express caution regarding broad market volatility and the impact of headline-driven price swings.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently trending as investors debate the impact of newly announced White House-backed air taxi integration pilot programs alongside ongoing legal friction with competitors regarding Chinese supply chain allegations. While bulls point to significant government contracts and FAA certification progress as proof of industry leadership, bears remain focused on high cash burn rates and intense volatility driven by aggressive institutional short-selling.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is currently seeing heavy community interest driven by anticipation of major contract wins and follow-on orders for its ultra-high-power wafer-level test and burn-in systems, particularly from key hyperscale data center and AI processor customers. Investors are closely tracking timelines for evaluation milestones and follow-on purchase orders, viewing the stock as a critical, undervalued play on the infrastructure expansion required for next-generation AI and silicon photonics hardware.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing significant volatility as investors weigh the company's aggressive $8.5 billion infrastructure financing deal against broader market headwinds and persistent insider selling. While some traders view the recent dip as a tactical entry point bolstered by optimistic analyst price targets and institutional backing, others are concerned about debt leverage and the potential for a cooling AI sector.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is trending as market participants digest conflicting reports regarding the potential de-escalation of military hostilities in the Middle East, with traders debating whether recent headlines signal a genuine shift in policy or another tactical maneuver. The community remains heavily divided, with intense discussions focused on the economic implications of persistent energy volatility and the credibility of administration communications amid broader market instability.

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Centessa Pharmaceuticals plc - ADR

Centessa Pharmaceuticals PLC - ADR

Centessa Pharmaceuticals is experiencing a significant surge in trading activity following the news that Eli Lilly has entered into a definitive agreement to acquire the company. Investors are actively discussing the details of this deal, which includes an upfront cash payment and a contingent value right, as part of a broader trend of increased M&A activity within the biotechnology and neuroscience sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TSLA 

Democrats will do anything including tanking the stock market and taking everybody’s money to make American suffer just to make Trump look bad ￼

George Betsios

StockTwits for iOS

 

Democrats will do anything including tanking the stock market and taking everybody’s money to make American suffer just to make Trump look bad ￼